AI may predict breast cancer return better than current methods
NCT ID NCT07541703
First seen Apr 24, 2026 · Last updated May 31, 2026 · Updated 7 times
Summary
This study looks at whether an artificial intelligence (AI) program can accurately predict if early-stage breast cancer will come back in a different part of the body. Researchers will analyze tissue samples and health records from 2,200 women who were previously treated for ER-positive, HER2-negative breast cancer. The goal is to see if the AI tool can help doctors decide which patients need more aggressive treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical University of Vienna, Center of Cancer Research
Vienna, Austria
Conditions
Explore the condition pages connected to this study.